MetLife Investment Management’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-27,124
Closed -$1.09M 2603
2021
Q3
$1.09M Hold
27,124
0.01% 1078
2021
Q2
$924K Hold
27,124
0.01% 1215
2021
Q1
$781K Sell
27,124
-5,639
-17% -$145K 0.01% 1269
2020
Q4
$595K Hold
32,763
0.01% 1398
2020
Q3
$867K Hold
32,763
0.01% 1100
2020
Q2
$631K Buy
32,763
+2,791
+9% +$49.5K 0.01% 1251
2020
Q1
$499K Hold
29,972
0.01% 1219
2019
Q4
$564K Hold
29,972
0.01% 1394
2019
Q3
$491K Hold
29,972
0.01% 1431
2019
Q2
$435K Hold
29,972
﹤0.01% 1568
2019
Q1
$373K Hold
29,972
﹤0.01% 1629
2018
Q4
$425K Hold
29,972
0.01% 1468
2018
Q3
$301K Hold
29,972
﹤0.01% 1857
2018
Q2
$297K Hold
29,972
﹤0.01% 1723
2018
Q1
$318K Hold
29,972
﹤0.01% 1647
2017
Q4
$450K Buy
+29,972
New +$477K 0.01% 1459

MetLife Investment Management's INOV Position: Q4 2021 in Review

MetLife Investment Management sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q4 2021, closing a stake of 27,124 shares — an estimated $1.09M sold.

MetLife Investment Management first reported a position in INOV in Q4 2017 and held it in 16 quarters. The position peaked at $1.09M in Q3 2021. 0 funds tracked by Wall St. Rank hold INOV as of Q4 2021.

  • MetLife Investment Management reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 27,124 Inovalon Holdings, Inc. Class A Common Stock shares in Q4 2021, an estimated $1.09M.
  • MetLife Investment Management first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q4 2017 and held it in 16 quarters.
  • MetLife Investment Management's Inovalon Holdings, Inc. Class A Common Stock position peaked at $1.09M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.